Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders

Part of paid clinical trials in Houston, Texas.

Sponsor
The University of Texas Health Science Center, Houston
Study ID
NCT06158607
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders — BEHAVIORAL
    Provision of PrEP information through 4 counseling sessions, prevention navigation, and nurse practitioner prescribed PrEP in an addiction treatment setting.
  • Standard of care treatment — OTHER
    Participants in substance use treatment will be given information and referral to a community partner who will evaluate them to determine if they could benefit from PrEP for HIV prevention

Study Details

The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase PrEP uptake and adherence compared to standard treatment Participants will * receive provision of PrEP information through 4 counseling sessions * prevention navigation * receive nurse practitioner prescribed PrEP in an addiction treatment setting Researchers will compare intervention group with standard treatment to see if the integrated intervention help increase PrEP uptake and adherence

Key Dates

Start date
Jun 7, 2022
Status verified
Dec 2024
Primary completion
May 30, 2025
Completion
May 30, 2025

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Intervention
  • Active Comparator: Standard of care treatment

Primary Outcome Measure

PrEP uptake [ Time Frame: 12 weeks post intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at HoustonHoustonTexas77054
Angela Heads
[email protected]
7134862830
Kaixuan An
[email protected]
(713) 486-2700

Find similar trials in Houston, TX

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston· Houston, TX

Related Studies